Subscribe to Newsletter

Rob Coker Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Content by Rob Coker:

 Discovery & Development Drug Discovery

Open Innovation Against Epilepsy

| Rob Coker | 2 min read

Angelini Pharma launches crowdsourcing project to tackle drug-resistant epilepsy
Discovery & Development Drug Delivery

Bladder Runner

| Rob Coker | 2 min read

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent
Discovery & Development Clinical Trials

Remote Research

| Rob Coker

A host of pharma industry experts discuss the increasing use of digital technology in decentralized clinical trials.
Discovery & Development Drug Discovery

Rosalind Franklin, We Salute You

| Rob Coker | 4 min read

Looking back on the achievements of Rosalind Franklin

Discovery & Development Clinical Trials

Drop the “D”

| Rob Coker | 4 min read

Experts consider how decentralized clinical trials will change in the future
Manufacture Bioprocessing - Upstream & Downstream

Propelling the Promise of mRNA

| Rob Coker | 4 min read

With mRNA technology scooping the 2023 Nobel Prize for Medicine, demand is growing. Can CDMOs keep up?
Manufacture Advanced Medicine

Notes, Quotes, and Anecdotes: Words of Wisdom from 2023

| Rob Coker | 5 min read

A selection of some of the most poignant words spoken by interviewees this year

Business & Regulation Standards & Regulation

Chemistry and Humility

| Rob Coker | 3 min read

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Business & Regulation Standards & Regulation

Nowhere to Hide

| Rob Coker | 2 min read

Never underestimate the meticulousness with which authorities operate or the standards that businesses are expected to adhere to.
Discovery & Development Clinical Trials

Body Positive

| Rob Coker | 2 min read

Almirall’s humanized monoclonal antibody treatment for psoriasis brings positivity for patients
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

April Issue of The Medicine Maker